Neonode Inks Licensing Pact for zForce Touch Screen Technology.

Neonode, Inc., an Optical Touchscreen Technology Company, said that it entered into a multi-year technology license agreement with another global retail electronics company to incorporate Neonode's touch screen solution into its family of products.

In a release, the Company said that this contract is potentially the largest technology license agreement it has signed to date. At the customer's request, due to product secrecy issues, the name of the customer and the product category cannot be released at this time.

"We have taken another important step towards our goal of gaining a significant market share for touch solutions. Another global company has chosen our touch screen solution, zForce, because low cost, fast and accurate full finger support in combination with high resolution pen support and low power consumption has once again proven to be at the forefront of the touch screen revolution," said Thomas Eriksson, CEO of Neonode Technologies AB. "We continue to experience a growing demand for our touch technology from companies around the world who produce a wide array of hand held consumer and industrial products such as mobile phones, e Readers, GPS devices, office equipment, tablet PCs to name a few," continued Eriksson.

Neonode said that its patented touch screen technology, zForce, supports high resolution pen writing in combination with finger navigation including gestures, multi-touch, sweeps and much more. zForce uses no overlay (like resistive and capacitive touch screens) on top of the display thus creating a 100 percent clear window, free from reflection and parallax effects producing a true clear viewing experience. Neonode's touch solution for portable devices is many times more cost effective than any other high performance touch solutions in the market today. zForce is currently integrated in or being integrated into products such as mobile phones, e Readers and mobile internet devices/tablet PC's.

((Comments on this story may be sent to health@closeupmedia.com))